Addition of adipose tissue-derived mesenchymal stem cells improves empagliflozin therapy for alleviating hyperglycemia--induced neuropathy
CONCLUSIONS: Combination of EMPA and ADMSC therapy was superior to either alone for improving outcomes of DN.PMID:37969202 | PMC:PMC10641353
Source: American Journal of Translational Research - Category: Research Authors: Hung-Sheng Lin Chien-Hui Yang Tsung-Cheng Yin Pei-Hsun Sung John Y Chiang Pei-Lin Shao Yi-Ling Chen Chi-Ruei Huang Hon-Kan Yip Kuan-Hung Chen Source Type: research
More News: Antidoxidants | Brain | Diabetes | Empagliflozin | Endocrinology | Jardiance | Men | Neurology | Pain | Research | Sodium | Stem Cell Therapy | Stem Cells | Study